HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 182 filers reported holding HERON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,414,359 | -10.9% | 8,169,280 | +0.4% | 0.00% | – |
| Q2 2023 | $9,443,237 | -25.8% | 8,140,722 | -3.4% | 0.00% | – |
| Q1 2023 | $12,730,233 | -34.8% | 8,430,618 | +8.0% | 0.00% | -100.0% |
| Q4 2022 | $19,515,712 | -47.2% | 7,806,285 | -10.8% | 0.00% | 0.0% |
| Q3 2022 | $36,938,000 | +66.3% | 8,752,841 | +9.9% | 0.00% | 0.0% |
| Q2 2022 | $22,214,000 | -60.9% | 7,962,197 | -19.9% | 0.00% | 0.0% |
| Q1 2022 | $56,827,000 | -35.2% | 9,934,688 | +3.4% | 0.00% | -50.0% |
| Q4 2021 | $87,730,000 | -13.6% | 9,609,045 | +1.1% | 0.00% | -33.3% |
| Q3 2021 | $101,558,000 | -29.8% | 9,500,292 | +1.9% | 0.00% | -25.0% |
| Q2 2021 | $144,643,000 | +5.1% | 9,319,728 | +9.8% | 0.00% | 0.0% |
| Q1 2021 | $137,642,000 | -21.8% | 8,491,216 | +2.2% | 0.00% | -20.0% |
| Q4 2020 | $175,919,000 | +48.4% | 8,311,768 | +3.9% | 0.01% | +25.0% |
| Q3 2020 | $118,577,000 | +0.4% | 8,001,099 | -0.4% | 0.00% | 0.0% |
| Q2 2020 | $118,115,000 | +26.0% | 8,029,538 | +0.6% | 0.00% | 0.0% |
| Q1 2020 | $93,738,000 | -49.2% | 7,984,465 | +1.6% | 0.00% | -33.3% |
| Q4 2019 | $184,628,000 | +43.5% | 7,856,566 | +12.9% | 0.01% | +20.0% |
| Q3 2019 | $128,687,000 | +2.6% | 6,956,047 | +3.1% | 0.01% | 0.0% |
| Q2 2019 | $125,387,000 | -20.0% | 6,744,858 | +5.2% | 0.01% | -16.7% |
| Q1 2019 | $156,770,000 | -4.3% | 6,414,507 | +1.6% | 0.01% | -14.3% |
| Q4 2018 | $163,794,000 | -16.4% | 6,314,339 | +2.0% | 0.01% | -12.5% |
| Q3 2018 | $196,016,000 | +11.3% | 6,193,249 | +36.7% | 0.01% | +14.3% |
| Q2 2018 | $176,066,000 | +128.1% | 4,531,931 | +62.0% | 0.01% | +133.3% |
| Q1 2018 | $77,203,000 | +76.4% | 2,797,188 | +15.7% | 0.00% | +50.0% |
| Q4 2017 | $43,754,000 | +30.9% | 2,417,280 | +16.8% | 0.00% | 0.0% |
| Q3 2017 | $33,422,000 | +15.1% | 2,069,493 | -1.3% | 0.00% | +100.0% |
| Q2 2017 | $29,036,000 | +3.2% | 2,096,465 | +11.8% | 0.00% | 0.0% |
| Q1 2017 | $28,127,000 | +60.5% | 1,875,103 | +40.2% | 0.00% | 0.0% |
| Q4 2016 | $17,522,000 | -22.4% | 1,337,540 | +2.0% | 0.00% | 0.0% |
| Q3 2016 | $22,588,000 | +3.0% | 1,310,980 | +7.9% | 0.00% | 0.0% |
| Q2 2016 | $21,937,000 | -0.2% | 1,215,343 | +5.0% | 0.00% | 0.0% |
| Q1 2016 | $21,978,000 | -25.3% | 1,157,304 | +5.0% | 0.00% | -50.0% |
| Q4 2015 | $29,433,000 | -84.1% | 1,102,364 | -82.7% | 0.00% | -71.4% |
| Q3 2015 | $184,862,000 | +562.6% | 6,377,962 | +612.4% | 0.01% | +250.0% |
| Q2 2015 | $27,898,000 | +186.5% | 895,326 | +33.8% | 0.00% | +100.0% |
| Q1 2015 | $9,738,000 | +68.1% | 669,311 | +16.2% | 0.00% | – |
| Q4 2014 | $5,793,000 | +23.2% | 575,807 | +2.0% | 0.00% | – |
| Q3 2014 | $4,702,000 | -21.6% | 564,533 | +15.9% | 0.00% | – |
| Q2 2014 | $5,999,000 | – | 486,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |